Calendar TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Delayed Nasdaq 09:53:59 2024-03-28 am EDT 5-day change 1st Jan Change
2.292 USD +1.84% Intraday chart for TherapeuticsMD, Inc. -0.37% +1.84%

Chart calendar TherapeuticsMD, Inc.

b6.Qd2Pg68zx7YZx3U2GdKI2P5v_pu9osySsGWRwVAK_Nw.MJzJtOxE9ulqnwUCVLDdrLkOv_HtlKDZ5lWm9wROvq82mPjHwmWqxCyINA~fc9ea80942fce6f40305d99d6a0ddc3c

Upcoming events on TherapeuticsMD, Inc.

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-07-29 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)

Past events on TherapeuticsMD, Inc.

2023-11-14 04:05 pm Q3 2023 Earnings Release
2023-08-14 06:50 am Q2 2023 Earnings Release
2023-06-26 08:00 am Annual General Meeting
2023-05-15 04:05 pm Q1 2023 Earnings Release
2023-04-07 04:01 pm Q4 2022 Earnings Release
2022-11-14 04:05 pm Q3 2022 Earnings Release
2022-08-15 08:30 am Interim 2022 Earnings Call
2022-08-15 06:50 am Interim 2022 Earnings Release
2022-05-16 04:30 pm Q1 2022 Earnings Call
2022-05-16 04:05 pm Q1 2022 Earnings Release
2022-03-10 08:30 am FY 2021 Earnings Call
2022-03-10 06:50 am FY 2021 Earnings Release
2021-11-11 08:30 am Q3 2021 Earnings Call
2021-11-11 06:50 am Q3 2021 Earnings Release
2021-08-04 08:30 am Interim 2021 Earnings Call
2021-08-04 06:50 am Interim 2021 Earnings Release
2021-05-27 08:00 am Annual General Meeting
2021-05-06 08:30 am Q1 2021 Earnings Call
2021-05-06 07:00 am Q1 2021 Earnings Release
2021-03-09 11:00 am H.C. Wainwright Global Life Science Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
16,1
15,7
2.74%
49,6
41,4
19.86%
64,9
63,3
2.43%
87,0
97,3
-10.62%
70,0
92,6
-24.45%
EBITDA
Million USD
Released
Forecast
Spread
-130
-130
0.3%
-151
-152
0.68%
-154
-141
-9.4%
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-130
-132
1.01%
-151
-152
0.5%
-156
-144
-8.33%
-140
-131
-6.29%
1,19
-73,5
101.62%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-133
-133
0.51%
-176
-176
-0.22%
-184
-171
-7.57%
-172
-163
-5.71%
1,07
23,8
-95.49%
Net income
Million USD
Released
Forecast
Spread
-133
-133
0.45%
-176
-176
-0.23%
-184
-171
-7.57%
-172
-163
-5.71%
112
23,5
376.58%
EPS
USD
Released
Forecast
Spread
-29,5
-29,1
-1.25%
-36,0
-34,9
-3.16%
-33,5
-30,5
-9.84%
-21,5
-20,2
-6.61%
12,0
2,47
384.21%
Announcement Date21/02/1920/02/2002/03/2110/03/2208/04/23

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales
Million USD
Released
Forecast
Spread
25,4
25,9
-1.8%
18,7
29,4
-36.45%
19,3
18,0
7.67%
28,6
23,2
23.11%
20,9
30,2
-30.74%
1,15
23,8
-95.16%
0,42
1,70
-75.53%
0,44
0,50
-12.6%
EBITDA
Million USD
Released
Forecast
Spread
-38,9
-33,0
-17.98%





















EBIT
Million USD
Released
Forecast
Spread
-39,9
-33,3
-19.94%
-35,4
-26,7
-32.35%
-26,2
-27,5
4.51%
-18,8
-23,5
19.99%



67,0
-7,70
970.23%
-2,67
0,70
-481%
-2,47
-0,70
-253.14%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-47,4
-39,7
-19.55%
-43,0
-33,3
-29.06%
-49,0
-34,0
-44.05%
113
-26,4
527.67%



-33,5
-10,8
-210.29%
-2,31
0,70
-430%
-2,41
-0,70
-244.86%
Net income
Million USD
Released
Forecast
Spread
-47,4
-39,7
-19.55%
-43,0
-33,3
-29.06%
-49,0
-34,0
-44.05%
112
-26,4
525.58%



77,7
-10,8
819.46%
-3,60
0,60
-700.5%
-2,41
-0,70
-244.86%
EPS
USD
Released
Forecast
Spread
-5,50
-5,00
-10%
-5,00
-3,83
-30.43%
-5,69
-4,00
-42.25%
12,4
-3,04
507.57%
-3,13
-2,04
-53.43%
8,23
-1,11
841.44%
-0,37
0,06
-716.67%
-0,24
-0,07
-242.86%
Announcement Date11/11/2110/03/2216/05/2215/08/2214/11/2208/04/2315/05/2314/08/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise